Actinic Keratosis
News
Melanoma incidence highest in Oregon, lowest in Texas in 2015
News
Overall survival plateaus at 3 years for ipilimumab-treated melanoma patients
Key clinical point: Ipilimumab-treated advanced melanoma patients alive at 3 years tend to have good long-term outcomes. Major finding: Around...
News
Xerosis is significant risk during targeted anticancer treatments
News
Patient-led teledermoscopy appears feasible and effective
Key clinical point: Patient-administered teledermoscopy using an iPhone-based mobile dermatoscope attachment and app is an effective and feasible...
News
Teledermoscopy referrals surpass paper for managing skin cancer patients
News
Handheld device illuminates possible routes of melanoma metastases
News
MEK inhibitors can induce skin eruptions with distinctive duskiness
Key clinical point: This MEK inhibitor–associated cutaneous eruption can be treated with a drug holiday and oral corticosteroid treatment,...
News
RNA sequencing characterized high-risk squamous cell carcinomas
Key clinical point: Squamous cell carcinomas from organ transplant recipients showed a more aggressive molecular profile than did those from...
Original Research
Reduced Degree of Irritation During a Second Cycle of Ingenol Mebutate Gel 0.015% for the Treatment of Actinic Keratosis
Ingenol mebutate gel is a topical field treatment of actinic keratosis (AK). One of several proposed mechanisms of action for ingenol mebutate is...
News
Ionizing radiation linked to BCC
Key clinical point: Ionizing radiation therapy significantly increased risk of basal cell carcinoma, especially when patients were younger or were...